Immune response to autologous and heterologous Helicobacter pylori antigens in humans. 2001

B Jakob, and S Birkholz, and T Schneider, and R Duchmann, and M Zeitz, and A Stallmach
Department of Internal Medicine II, Saarland University, Homburg/Saar, Germany.

Infection of humans with Helicobacter pylori results in the development of chronic gastritis and plays an important role in gastric ulcer pathogenesis. Despite the infiltration of the mucosa with specific immunocompetent cells and production of specific antibodies, the infection usually persists for life. This study was performed to investigate if immunologic mechanisms exist which could contribute to the inability of the host to terminate the infection. Therefore, we compared the in vitro immunoreactivity of peripheral blood mononuclear cells (PBMC) from H. pylori-infected patients after stimulation with sonicated H. pylori bacteria from the stomach of the patient (autologous bacterial strain) with stimulation by bacteria from other patients (heterologous bacteria). We measured cell proliferation, expression of T cell activation markers CD25, HLA-DR, and CD71, as well as production ofinterleukin-10 (IL-10), an inhibitory cytokine. We found that the proliferative response of PBMC was significantly lower after autologous than after heterologous stimulation. Furthermore, secretion of IL-10 in the culture supernatants was significantly higher when PBMC were incubated with autologous than with heterologous H. pylori antigens. No significant differences between autologous or heterologous stimulation were observed in the increased expression of T cell activation markers. These data indicate that systemic immunologic response to H. pylori are strain-dependent. For further studies of the immune responses towards H. pylori, the use of an autologous stimulatory system seems necessary.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial
D016480 Helicobacter pylori A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405). Campylobacter pylori,Campylobacter pylori subsp. pylori,Campylobacter pyloridis,Helicobacter nemestrinae

Related Publications

B Jakob, and S Birkholz, and T Schneider, and R Duchmann, and M Zeitz, and A Stallmach
November 1997, Microbial pathogenesis,
B Jakob, and S Birkholz, and T Schneider, and R Duchmann, and M Zeitz, and A Stallmach
July 2017, Journal of Korean medical science,
B Jakob, and S Birkholz, and T Schneider, and R Duchmann, and M Zeitz, and A Stallmach
April 2001, Journal of clinical microbiology,
B Jakob, and S Birkholz, and T Schneider, and R Duchmann, and M Zeitz, and A Stallmach
September 1999, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
B Jakob, and S Birkholz, and T Schneider, and R Duchmann, and M Zeitz, and A Stallmach
November 2010, Folia microbiologica,
B Jakob, and S Birkholz, and T Schneider, and R Duchmann, and M Zeitz, and A Stallmach
March 1996, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society,
B Jakob, and S Birkholz, and T Schneider, and R Duchmann, and M Zeitz, and A Stallmach
June 1998, World journal of gastroenterology,
B Jakob, and S Birkholz, and T Schneider, and R Duchmann, and M Zeitz, and A Stallmach
December 2003, Clinical and experimental immunology,
B Jakob, and S Birkholz, and T Schneider, and R Duchmann, and M Zeitz, and A Stallmach
January 2024, Helicobacter,
B Jakob, and S Birkholz, and T Schneider, and R Duchmann, and M Zeitz, and A Stallmach
January 1995, Scandinavian journal of gastroenterology. Supplement,
Copied contents to your clipboard!